Consistent with previous findings, analysis of cancer genomics data in several GBM patient databases using the cBioPortal tool18 showed that EGFR amplification (46%) and PTEN deletion (25%) frequently occur in GBM (Figure 1A). Here, EGFR is linked to glioblastoma.